Berlin-based digital health company Ada Health has announced a $90 million (€74m) Series B funding investment led by Leaps by Bayer, the impact investment arm of Bayer AG, which will support the company with its expertise in scientific innovation and consumer healthcare.
Other investors in the round include Samsung Catalyst Fund, Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures.
This...
This morning Medopad, an artificial intelligence-enabled patient data collection and analytics platform, landed $25 million in Series B funding. The last round was led by pharma giant Bayer’s venture capital branch Leaps by Bayer.
This new announcement brings the UK-based company’s total funding to $50 million, and comes roughly a year and a half after it closed its $28 million Series A round....
